ArticleClosed2026CTLA-4/PD-1, LAG-3, and TIGIT Inhibitors: Emerging Drug Targets and Combination Strategies in Hepatocellular CarcinomaCurrent Cancer Drug TargetsTIGITImmune systemMedicineHepatocellular carcinoma